Are glycineB sites involved in the development of morphine tolerance?

Polish Journal of Pharmacology

Volumn 56, Issue 1, 2004, Pages 51-57

  Kotlińska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Hot plate test; Morphine; NMDA antagonists; Rats; Tolerance

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; DIZOCILPINE; GLYCINE B; GLYCINE DERIVATIVE; GLYCINE RECEPTOR ANTAGONIST; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; DIZOCILPINE MALEATE; GLYCINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOLONE DERIVATIVE;

ANALGESIA; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; DRUG TOLERANCE; HOT PLATE TEST; LATENT PERIOD; MALE; NONHUMAN; PHARMACODYNAMICS; RAT; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; METHODOLOGY; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PHYSIOLOGY; POLAND; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; DIZOCILPINE MALEATE; DRUG SYNERGISM; DRUG TOLERANCE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; PAIN MEASUREMENT; POLAND; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 1942485259     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Belozertseva IV, Bespalov AY: Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeates in mice. Naunyn Schmiedebergs Arch Pharmacol, 1999, 358, 270-274.
2. Belozertseva IV, Danysz W, Bespalov AY. Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice. Naunyn Schmiedebergs Arch Pharmacol, 2000, 231, 279-282.
3. Belozertseva, IV, Danysz W, Bespalov AY. Effects of short-acting NMDA receptor antagonist MRZ 2/576 on morphine tolerance development in mice. Naunyn Schmiedebergs Arch Pharmacol, 2000, 361, 573-577.
4. Bhargava HN, Matwyshyn GA: Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology, 1993, 47, 344-350.
5. Bilsky EJ, Inturrisi CE, Sadee W, Hruby VJ, Porreca F: Competitive and non-competitive NMDA antagonists block the development of antintinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain, 1996, 68, 229-237.
6. Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D et al.: Anticonvulsant and behavioral profile of L-701.324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex. J Pharmacol Exp Mer, 1996, 279, 492-501.
7. Commons KG, van Bockstaele EJ, Pfaff DW: Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J Comp Neurol, 1999, 408, 549-559.
8. Danysz W, Parsons CG: Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev, 1998, 50, 597-664.
9. Danysz W, Zajaczkowski W, Parsons CG: Modulation of leaming processes by ionotropic glutamate receptor ligands. Behav Pharmacol, 1995, 6, 455-474.
10. Dewey WL, Harris LS: The tail flick test. In: Methods in Narcotic Research. Ed. Ehrenpreis S, Neidle A, Marcel Dekker, New York, 1975, 101-109.
11. g-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain, 1994, 56, 69-75.
12. Herman BH, O'Brien CP: Clinical medications development for opiate addiction: focus on nonopioids and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention. Semin Neurosci, 1997, 9, 158-172.
13. Herman BH, Vocci F, Bridge P: The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: medication development issues for opiate addiction. Neuropsychopharmacology, 1995, 13, 269-293.
14. Jensen TS, Yaksh TL: Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedical medulla in rat. Brain Res, 1986, 363, 99-113.
15. Johnson JW, Ascher P: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature, 1987, 325, 529-531.
16. Kolesnikov YA, Maccecchini ML, Pasternak GW: 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci, 1994, 55, 1393-1398.
17. Kosten TA, DeCaprio JL, Rosen MI: The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist. Neuropsychopharmacology, 1995, 13, 323-333.
18. B site antagonists in rats. Pharmacol Biochem Behav, 2001, 68, 157-161.
19. Kothnska J, Liljequist S: Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures. Psychopharmacology, 1996, 127, 238-244.
20. Kozela E, Danysz W, Popik P: Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Eur J Pharmacol, 2001, 423, 17-26.
21. Luger TJ, Lorenz IH, Grabner-Weiss C, Hayashi T: Effect of the NMDA-antagonist, MK 801, on benzodizepine-opioid interactions at the spinal and supraspinal level in rats. Br J Pharmacol, 1995, 114, 1097-1103.
22. Lutfy K, Doan P, Weber E: ACEA-1328, a NMDAreceptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol Res, 1999, 40, 435-442.
23. Lutfy & Hurlbut DE, Weber E: Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res, 1993, 616, 83-88.
24. Lutfy K, Shen K-Z, Kwon I-S, Cai SX, Woodward RM, Keana JFW, Weber E: Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine antagonist. Eur J Pharmacol, 1995, 273, 187-189.
25. Mao J: NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev, 1999, 30, 289-304.
26. Medvedev IO, Dravolina, OA, Bespalov AY. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm. J Pharmacol Exp Ther, 1998, 286, 1260-1268.
27. Rasmussen & Krystal JH, Aghajanian GK: Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology, 1991, 105, 508-512.
28. Siegel S: Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model. Science, 1976, 193, 323-325.
29. Spinella M, Cooper ML, Bodnar RJ: Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain, 1996, 64, 545-552.
30. Tortela FC, Pellicano M, Bowery NG: Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci, 1989, 10, 501-507.
31. Trujillo KA: Are NMDA receptors involved in opiateinduced neural and behavioral plasticity? Psychopharmacology, 2000, 151, 121-141.
32. Trujillo KA, Akil H: Inhibition of morphine tolerance by the NMDA receptor antagonist MK-801. Science, 1991, 251, 85-87.
33. Tzschentke TM, Schmidt WJ: Does the non-competitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? Trends Pharmacol Sci, 1998, 19, 447-451.
34. Yaksh TL, Dirksen R, Harty G: Antinociceptive action of intrathecally administered cholinomimetics in rat and cat. Eur J Pharmacol, 1985, 117, 81-88.
35. Zhu H, Brodsky M, Gorman L, Inturrisi CE: Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614. Brain Res Mol Brain Res, 2003, 114, 154-162.